681 related articles for article (PubMed ID: 23074134)
21. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.
Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J
Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715
[TBL] [Abstract][Full Text] [Related]
22. Three-month experience with tacrolimus once-daily regimen in stable renal allografts.
Diez Ojea B; Alonso Alvarez M; Aguado Fernández S; Baños Gallardo M; García Melendreras S; Gómez Huertas E
Transplant Proc; 2009; 41(6):2323-5. PubMed ID: 19715908
[TBL] [Abstract][Full Text] [Related]
23. A 6-month, multicenter, single-arm pilot study to evaluate the efficacy and safety of generic tacrolimus (TacroBell) after primary renal transplantation.
Kim SJ; Huh KH; Han DJ; Moon IS; Kim SJ; Kim YL; Kim HC; Lee S; Kang CM; Cho BH; Kim YS
Transplant Proc; 2009 Jun; 41(5):1671-4. PubMed ID: 19545705
[TBL] [Abstract][Full Text] [Related]
24. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
26. Resource use and cost implications of switching among warfarin formulations in atrial fibrillation patients.
Kwong WJ; Kamat S; Fang C
Ann Pharmacother; 2012 Dec; 46(12):1609-16. PubMed ID: 23150608
[TBL] [Abstract][Full Text] [Related]
27. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
[TBL] [Abstract][Full Text] [Related]
28. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
[TBL] [Abstract][Full Text] [Related]
29. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients.
Kim JM; Kwon CHD; Joh JW; Sinn DH; Choi GS; Park JB; Kang ES; Lee SK
Med Princ Pract; 2017; 26(3):221-228. PubMed ID: 28092916
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients.
Choi HJ; Kim DG; Kwak BJ; Han JH; Hong TH; You YK
Drug Des Devel Ther; 2018; 12():295-301. PubMed ID: 29483770
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
Nakamura Y; Hama K; Katayama H; Soga A; Toraishi T; Yokoyama T; Kihara Y; Jojima Y; Konno O; Iwamoto H; Takeuchi H; Hirano T; Shimazu M
Transplant Proc; 2012 Jan; 44(1):124-7. PubMed ID: 22310595
[TBL] [Abstract][Full Text] [Related]
32. Comparison of generic tacrolimus and Prograf drug levels in a pediatric kidney transplant program: brief communication.
Abdulnour HA; Araya CE; Dharnidharka VR
Pediatr Transplant; 2010 Dec; 14(8):1007-11. PubMed ID: 20819180
[TBL] [Abstract][Full Text] [Related]
33. Tacrolimus conversion in kidney transplant recipients: analysis of 107 patients.
Yağmurdur MC; Sevmis S; Emiroğlu R; Moray G; Bilgin N; Haberal M
Transplant Proc; 2004; 36(1):144-7. PubMed ID: 15013327
[TBL] [Abstract][Full Text] [Related]
34. Safe conversion to cicloral, a generic cylosporine, in both stable and de novo renal transplant recipients.
Kahn D; Muller E; Pascoe M
Saudi J Kidney Dis Transpl; 2010 May; 21(3):426-32. PubMed ID: 20427863
[TBL] [Abstract][Full Text] [Related]
35. Generic Tacrolimus (Tacrobell
Kim JM; Joh JW; Choi GS; Lee SK
Drug Des Devel Ther; 2019; 13():4431-4438. PubMed ID: 32021085
[TBL] [Abstract][Full Text] [Related]
36. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
Kuypers DR; Vanrenterghem Y
Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients.
Lichvar A; Tremblay S; Naik D; Lipscomb J; King E; Vinks AA; Christians U; Alloway RR
Pharmacotherapy; 2019 May; 39(5):564-575. PubMed ID: 30892704
[TBL] [Abstract][Full Text] [Related]
38. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation.
Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML
JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-2 profiles shortly after tacrolimus conversion from a twice-daily to once-daily regimen.
Meçule A; Tinti F; Bachetoni A; Poli L; D'Alessandro M; Alessandri C; Umbro I; Nofroni I; Berloco PB; Mitterhofer AP
Transplant Proc; 2011 May; 43(4):1017-9. PubMed ID: 21620040
[TBL] [Abstract][Full Text] [Related]
40. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring.
Melilli E; Crespo E; Sandoval D; Manonelles A; Sala N; Mast R; Padulles A; Grinyo JM; Bestard O; Cruzado JM
Transpl Int; 2015 Nov; 28(11):1283-90. PubMed ID: 26088437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
